文献速递前列腺增生与排尿功能障碍肾癌与肾肿瘤

肥胖、代谢综合征与糖尿病同尿失禁及慢性肾病的关联:2003-2020年美国国家健康与营养调查分析

Association of Obesity, Metabolic Syndrome, and Diabetes With Urinary Incontinence and Chronic Kidney Disease: Analysis of the National Health and Nutrition Examination Survey, 2003-2020.
PubMed 文献 · J Urol · 2023-10-20

基于2003-2020年美国国家健康与营养调查中8586名男性和8420名女性的数据,采用多因素logistic回归分析发现,非糖尿病代谢综合征/肥胖表型与尿失禁及慢性肾病存在性别特异性关联,且合并尿失禁与慢性肾病的比值比高于单一疾病。

要点

  • 男性代谢综合征/肥胖者非糖尿病尿失禁比值比为1.25(95%CI 1.00-1.57),急迫性尿失禁为1.36(1.03-1.80)。
  • 女性代谢综合征/肥胖者非糖尿病尿失禁比值比为2.16(95%CI 1.76-2.66),压力性尿失禁为1.51(1.21-1.87),混合性尿失禁为1.66(1.31-2.11)。
  • 糖尿病、男性代谢综合征/肥胖表型及女性代谢综合征表型者合并尿失禁与慢性肾病的比值比高于单一疾病。

核心结论

  • 在无糖尿病人群中发现代谢综合征/肥胖与男性急迫性尿失禁的新关联,以及代谢综合征和肥胖分别与女性压力性尿失禁的关联。
  • 现有肥胖或代谢综合征使尿失禁/慢性肾病合并发生的比值比高于单一尿失禁或慢性肾病。
  • 加深对尿失禁可改变相关因素的理解将为预防和治疗提供机会。

研究设计与样本

  • 分析2003-2020年美国国家健康与营养调查中8586名男性和8420名年龄≥20岁女性的数据。
  • 采用多因素logistic回归模型分析尿失禁或慢性肾病与糖尿病及4种非糖尿病肥胖/代谢表型(非代谢综合征/非肥胖、代谢综合征/非肥胖、非代谢综合征/肥胖、代谢综合征/肥胖)的关联。
  • 采用多项logistic回归模型评估尿失禁与慢性肾病共现与肥胖/代谢表型的关联。

主要发现

  • 男性代谢综合征/肥胖参与者与非代谢综合征/非肥胖者相比,任何尿失禁的比值比为1.25(95%CI 1.00-1.57),急迫性尿失禁为1.36(95%CI 1.03-1.80)。
  • 女性代谢综合征/肥胖参与者与非代谢综合征/非肥胖者相比,任何尿失禁的比值比为2.16(95%CI 1.76-2.66),压力性尿失禁为1.51(95%CI 1.21-1.87),混合性尿失禁为1.66(95%CI 1.31-2.11)。
  • 糖尿病者、男性代谢综合征/肥胖表型者及女性代谢综合征表型者,相较于同性别既无肥胖也无代谢综合征者,尿失禁与慢性肾病共现的比值比高于单一尿失禁或慢性肾病。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Diabetes and obesity, components of the metabolic syndrome (MetS), are risk factors for urinary incontinence (UI) and chronic kidney disease (CKD). We interrogated US population-based data to explore independent, sex-specific associations between nondiabetic MetS, with and without obesity, and UI and/or CKD. MATERIALS AND METHODS: We analyzed data from 8586 males and 8420 females ≥20 years from the National Health and Nutrition Examination Survey. Multivariable logistic regression models were used to examine associations of UI or CKD with diabetes and 4 nondiabetic obesity/metabolic phenotypes: non-MetS/nonobese, MetS/nonobese, non-MetS/obese, and MetS/obese. Multinominal logistic regression models were used to assess associations of co-occurring UI/CKD with obesity/metabolic phenotypes. RESULTS: Male MetS/obese participants had increased odds of any UI (1.25; 95% CI 1.00-1.57) and urgency UI (1.36; 1.03-1.80), compared with non-MetS/nonobese participants. Female MetS/obese participants had increased odds of any UI (2.16; 95% CI 1.76-2.66), stress UI (1.51; 1.21-1.87), and mixed UI (1.66; 1.31-2.11) compared with non-MetS/nonobese participants. The odds of co-occurring UI/CKD were increased relative to either condition alone in persons with diabetes, and in males with MetS/obese phenotypes and females with MetS phenotypes as compared to same sex participants with neither obesity nor MetS. CONCLUSIONS: We found novel associations between MetS/obese and urgency UI in males without diabetes, and between SUI and both MetS and obesity in females without diabetes. Odds estimates for UI/CKD were increased by existing obesity or MetS as compared to those for UI or CKD alone. Improved understanding of modifiable factors associated with UI will inform prevention and treatment opportunities.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Fwu CW, Schulman IH, Lawrence JM, et al. Association of Obesity, Metabolic Syndrome, and Diabetes With Urinary Incontinence and Chronic Kidney Disease: Analysis of the National Health and Nutrition Examination Survey, 2003-2020. J Urol. 2023. PMID: 37862455. doi:10.1097/JU.0000000000003761

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。